Rallybio Corp
For the period ended Dec 31, 2023. Filed Mar 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 12, 2024
RLYB$15.66-0.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except share and per share amounts) | DECEMBER 31,2023 | DECEMBER 31,2022 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $24,494 | $56,958 |
| Marketable securities | 85,435 | 112,036 |
| Prepaid expenses and other assets | 4,860 | 10,502 |
| Total current assets | 114,789 | 179,496 |
| Property and equipment, net | 246 | 385 |
| Operating lease right-of-use assets | 346 | 524 |
| Investment in joint venture | 239 | 30 |
| Total assets | $115,620 | $180,435 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $976 | $1,114 |
| Accrued expenses | 8,068 | 9,449 |
| Operating lease liabilities | 219 | 181 |
| Total current liabilities | 9,263 | 10,744 |
| Operating lease liabilities, noncurrent | 173 | 374 |
| Total liabilities | 9,436 | 11,118 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' equity | ||
| Common stock, $0.0001 par value per share; 200,000,000 shares authorized as of December 31, 2023 and 2022, respectively; and 37,829,565 and 37,837,369 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 4 | 4 |
| Preferred stock, $0.0001 par value per share; 50,000,000 shares authorized as of December 31, 2023 and 2022, respectively; no shares issued or outstanding as of December 31, 2023 and 2022, respectively | — | — |
| Additional paid-in capital | 341,410 | 330,208 |
| Accumulated other comprehensive gain (loss) | 15 | (214) |
| Accumulated deficit | (235,245) | (160,681) |
| Total stockholders' equity | 106,184 | 169,317 |
| Total liabilities and stockholders' equity | $115,620 | $180,435 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.